Interpreting Lab Results and the B12 Paradox

In many medical conditions, a “normal” lab result is a sign that everything is fine. However, Transcobalamin II (TCII) deficiency is defined by a confusing biochemical paradox: your baby can have normal or even high levels of Vitamin B12 in their blood while their cells are simultaneously starving for it ^[1][2].

Understanding how to read these lab reports is a vital skill for managing your child’s care. Because the standard B12 test only measures what is “floating” in the blood—not what is actually getting inside the cells—doctors must look at “functional” markers to see the true picture ^[1][3].

The Biochemical Markers: MMA and Homocysteine

When cells lack Vitamin B12, two specific substances begin to build up in the body like water behind a dam. These are important markers for you to track:

1. Methylmalonic Acid (MMA): B12 is a required “helper” for an enzyme that breaks down MMA. If B12 can’t get into the cell, MMA levels skyrocket in both the blood and the urine ^[4][2].
2. Total Homocysteine (tHcy): Similarly, B12 is needed to convert homocysteine into an essential amino acid called methionine. High homocysteine is a major red flag that the B12 transport system is broken ^[2][4].

Note on Monitoring: Your metabolic team will use serial (repeated) measurements of MMA and homocysteine to help adjust your child’s B12 dosage ^[2]. However, they are not direct measurements of brain delivery. They can be affected by renal function, folate or vitamin B6 status, age, nutrition, and other metabolic disorders. Dose changes require the specialist to consider the CBC, clinical condition, renal function, treatment timing, and the whole diagnostic picture, rather than relying on one lab alone.

Newborn Screening and the C3/C2 Ratio

In some states and regions, TCII deficiency is caught incidentally during newborn screening. The screen looks for a marker called C3 (propionylcarnitine) and compares it to another marker called C2 ^[5][6].

• How it works: Because TCII deficiency stops the cell from using B12, it causes a backup in the metabolic pathway that produces C3. This leads to an elevated C3/C2 ratio ^[6].
• The Limitation: C3 and C3/C2 cutoffs differ by screening program. An elevated C3 can result from propionic acidemia, methylmalonic disorders, cobalamin-processing disorders, maternal B12 deficiency, or other factors. A normal screen cannot exclude TCII deficiency, and any abnormal screen requires prompt confirmatory testing rather than reassurance ^[6].

Your Completeness Checklist

To confirm a diagnosis and rule out “look-alike” conditions, your medical team should perform a comprehensive set of tests. You may want to ensure the following have been completed:

How to Read the Genetic Report

The definitive molecular diagnosis requires genetic testing of the TCN2 gene, including deletion-duplication analysis ^[7]. Confirmation generally requires biallelic pathogenic or likely pathogenic TCN2 variants, usually one inherited from each parent ^[9][10].

If the report mentions a “variant of uncertain significance” (VUS), it is not a confirmed diagnosis. A VUS cannot be classified as disease-causing from MMA and homocysteine alone. Interpretation may require parental testing to determine variant phasing, functional/clinical correlation, genetic counseling, and later reanalysis. A negative panel may require genetics review rather than automatically excluding the diagnosis ^[7].